The Annual General Meeting of Pharmexa A/S was held on Tuesday April 28, 2009
at 4:00 pm.
The annual report was approved.
The board of directors and the management was not given discharge.
The board of directors' proposal to distribution of the profit or settlement of
loss was approved.
The proposal by a shareholder that the general meeting should adopt a vote of
no confidence in the present board of directors and order the board members to
resign was not approved.
Ole Steen Andersen, Karl Olof Borg, Alf Lindberg, Karen Lykke Sørensen and
Michel Pettigrew were re-elected for the board. Jørgen Buus Lassen leaves the
board due to the age limit of 75 years in the Articles of Association. After
the meeting the board constituted itself with Ole Steen Andersen as the
chairman.
Ernst & Young was re-elected as state authorised accountants.
Hørsholm, April 29, 2009
Achim Kaufhold
Chief Executive Officer
Additional information:
Achim Kaufhold, CEO, tel +45 4516 2525
Claude Mikkelsen, Senior Vice President, Finance & Investor Relations, tel +45
4516 2525 or +45 4060 2558
